Evidence map›Paper›PMID 28205097›Full record

ArticleMolecular and cellular biochemistry2017

Identifying and characterising PPE7 (Rv0354c) high activity binding peptides and their role in inhibiting cell invasion.

Diana P Díaz, Marisol Ocampo, Yahson Varela, Hernando Curtidor, Manuel A Patarroyo, Manuel E Patarroyo

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Diana P DíazFundación Instituto de Inmunología de Colombia (FIDIC), 111321, Bogotá, Colombia.
Marisol OcampoFundación Instituto de Inmunología de Colombia (FIDIC), 111321, Bogotá, Colombia. Marisol.ocampo@urosario.edu.co.ORCID http://orcid.org/0000-0001-9764-0052
Yahson VarelaFundación Instituto de Inmunología de Colombia (FIDIC), 111321, Bogotá, Colombia.
Hernando CurtidorFundación Instituto de Inmunología de Colombia (FIDIC), 111321, Bogotá, Colombia.
Manuel A PatarroyoFundación Instituto de Inmunología de Colombia (FIDIC), 111321, Bogotá, Colombia.
Manuel E PatarroyoFundación Instituto de Inmunología de Colombia (FIDIC), 111321, Bogotá, Colombia.
Fundación Instituto de Inmunología de Colombia · COUniversidad Nacional de Colombia · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study was aimed at characterising the PPE7 protein from the PE/PPE protein family. The presence and transcription of the rv0354c gene in the Mycobacterium tuberculosis complex was determined and the subcellular localisation of the PPE7 protein on mycobacterial membrane was confirmed by immunoelectron microscope. Two peptides were identified as having high binding activity (HABPs) and were tested in vitro regarding the invasion of Mycobacterium tuberculosis H37Rv. HABP 39224 inhibited invasion in A549 epithelial cells and U937 macrophages by more than 50%, whilst HABP 39225 inhibited invasion by 40% in U937 cells. HABP 39224, located in the protein's C-terminal region, has a completely conserved amino acid sequence in M. tuberculosis complex species and could be selected as a base peptide when designing a subunit-based, anti-tuberculosis vaccine.

Indexed as

Bacterial ProteinsCell MembraneMycobacterium tuberculosisA549 CellsHumansTuberculosis VaccinesU937 CellsBacterial ProteinsTuberculosis VaccinesHigh activity binding peptideMycobacterium tuberculosis H37RvPPE7 proteinSynthetic peptide

Identifiers

PMID28205097
OpenAlexW2588269274

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.